TBX5基因在结直肠癌中的临床意义及机制研究
该研究检测了90例结直肠癌及癌旁组织中TBX5的表达,发现癌组织TBX5阳性率显著低于癌旁组织,且低表达与淋巴结转移、浸润深度、神经侵犯及较差生存相关;体外实验表明过表达TBX5可抑制HT-29细胞增殖、迁移和侵袭,并调控增殖与侵袭相关基因表达。
要点
- 结直肠癌组织TBX5阳性率24.44%,显著低于癌旁组织65.56%。
- TBX5低表达与淋巴结转移、浸润深度、神经侵犯及较差生存相关。
- 过表达TBX5可抑制HT-29细胞增殖、迁移和侵袭并调控相关基因。
核心结论
- TBX5低表达是结直肠癌患者预后差的标志,TBX5可能通过抑制增殖和侵袭转移相关基因而抑制结直肠癌进展。
研究设计与样本
- 研究纳入90例结直肠癌组织和癌旁正常黏膜组织,采用免疫组化检测TBX5表达并分析临床病理特征及预后关系。
- 体外选用HT29、SW620、SW480、LOVO、HCT116五种人结肠癌细胞株检测TBX5表达。
- 构建TBX5高表达质粒转染HT-29细胞,设阴性对照组和空白对照组。
主要发现
- 结直肠癌组织TBX5蛋白阳性率为24.44%(22/90),显著低于癌旁组织的65.56%(P<0.001)。
- TBX5表达与浸润深度、淋巴结转移及神经侵犯有关(均P<0.05)。
- TBX5阳性22例患者生存时间为(60.2±2.4)个月,优于阴性68例患者的(44.3±2.8)个月(P<0.05)。
- 五种结肠癌细胞株中HT29细胞TBX5的mRNA和蛋白表达最弱。
- 转染组TBX5表达显著高于阴性对照组和空白对照组(P=0.043,P<0.001)。
关键数值与推荐
- 转染组细胞吸光度显著低于阴性对照组和空白对照组(均P<0.001)。
- 转染组G(0)/G(1)期细胞比例升高(P=0.009),G(2)/M期细胞比例降低(P<0.001)。
- 转染组细胞迁移和侵袭能力显著降低(均P<0.001)。
- 转染组PCNA、MMP-2、MMP-7表达减弱,p21、p16、p27表达增强(均P<0.05)。
- TIMP-1表达无明显变化(P>0.05)。
临床怎么用
- TBX5低表达可作为结直肠癌预后不良的潜在标志物。
- TBX5可能成为抑制结直肠癌增殖和侵袭转移的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To examine the expression of T-box5 (TBX5) in colorectal cancer tissues and its clinical significance, and explore the effects of TBX5 on the invasion and metastasis of colorectal cancer cells and its mechanism. Methods: The expressions of TBX5 in cancer and adjacent normal tissues were tested by immunohistochemistry (IHC), and the relationship between TBX5 and clinicopathological features and prognosis of colorectal cancer was analyzed. Real-time quantitative PCR (RT-qPCR) and western blot were used to detect the expressions of TBX5 in different colorectal cancer cell lines. TBX5 overexpression plasmid was constructed and transfected into human colorectal cancer cell line HT-29, and cell counting kit-8 (CCK-8) was used to detect the activities of transfection HT-29 cells. Cell scratch test and Transwell assay were used to detect the migration and invasion abilities of cells, while RT-qPCR and western blot were used to detect the mRNA and protein expressions of PCNA, p21, p16, p27, MMP-2, MMP-7 and TIMP-1. Results: The positive rate of TBX5 protein in colorectal cancer tissues was 24.44% (22/90), significantly lower than 65.56% of adjacent normal tissues (P<0.001). The expression of TBX5 was significantly related to lymph node metastasis, depth of invasion and nerve invasion (P<0.05). The survival period of 22 patients with positive TBX5 expression was (60.2±2.4) months, better than (44.3±2.8) months of 68 patients with negative TBX5 expression (P<0.05). Among human colon cancer cell lines of HT29, SW620, SW480, LOVO and HCT116, the expression of TBX5 in HT29 cells was the weakest. After transfection, the expression of TBX5 in transfection group was significantly higher than those in control group and blank group (P=0.043 and P<0.001). Cell viability in transfection group was significantly lower than those in control group and blank group (both P<0.001). The ratio of cells in G(0)/G(1) phase was increased (P=0.009), while in G(2)/M phase was decreased (P<0.001). Cells' abilities of migration and invasion in transfection group were also significantly decreased (both P<0.001). Overexpression of TBX5 downregulated the expressions of PCNA, MMP-2 and MMP-7, while upregulated the expressions of p21, p16, p27 (P<0.05 for all). TBX5 had marginal effect on the expression of TIMP-1 (P>0.05). Conclusions: Downregulation of TBX5 is a marker of poor prognosis in patients with colorectal cancer. TBX5 may inhibit the progression of colorectal cancer by inhibiting proliferation, invasion and metastasis related genes. 目的: 探讨T-框蛋白5(TBX5)基因在结直肠癌组织中的表达,TBX5对结直肠癌细胞侵袭转移能力的影响及机制。 方法: 免疫组化法检测90例结直肠癌组织和癌旁正常黏膜组织中TBX5的表达,分析TBX5表达与结直肠癌患者临床病理特征及预后的关系。实时荧光定量聚合酶链反应(RT-qPCR)和Western blot检测不同结直肠癌细胞株中TBX5的表达。合成TBX5高表达质粒,转染人结直肠癌细胞株HT-29,细胞计数试剂盒8法检测细胞活性,细胞划痕实验和Transwell小室侵袭实验检测细胞的迁移侵袭能力,RT-qPCR和Western blot法检测增殖细胞核抗原(PCNA)、基质金属蛋白酶2(MMP-2)、MMP-7、p21、p16、p27、基质金属蛋白酶组织抑制因子1(TIMP-1)的mRNA和蛋白表达情况。 结果: 结直肠癌组织中TBX5蛋白表达的阳性率为24.44%(22/90),明显低于癌旁组织(65.56%,P<0.001)。结直肠癌组织中TBX5的表达与浸润深度、淋巴结转移及神经侵犯有关(均P<0.05)。结直肠癌组织中TBX5蛋白表达阳性的22例患者生存时间为(60.2±2.4)个月,优于表达阴性的68例患者[(44.3±2.8)个月,P<0.05]。人结肠癌细胞株HT29、SW620、SW480、LOVO、HCT116中,HT29细胞TBX5的mRNA和蛋白表达最弱。TBX5转染组HT29细胞中TBX5的mRNA和蛋白表达均明显高于阴性对照组和空白对照组(P=0.043,P<0.001),吸光度明显低于阴性对照组和空白对照组(均P<0.001),G(0)/G(1)期细胞比例升高(P=0.009),G(2)/M期细胞比例降低(P<0.001),迁移和侵袭能力明显降低(均P<0.001)。TBX5转染组细胞的PCNA、MMP-2、MMP-7表达减弱,而p21、p16、p27表达增强(均P<0.05),TIMP-1表达无明显变化(P>0.05)。 结论: TBX5低表达是结直肠癌患者预后差的标志,TBX5可能是通过抑制增殖和侵袭转移相关基因而抑制了结直肠癌的进展。.
引用
- Dong MJ, Zhou Y, Duan M, et al. [Clinical significance and mechanism of TBX5 gene in colorectal cancer]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32482027. doi:10.3760/cma.j.cn112152-112152-20190829-00560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。